Literature DB >> 4208196

Interactions of sulfonylureas with plasma proteins.

P L Hsu, J K Ma, L A Luzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4208196     DOI： 10.1002/jps.2600630416

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

Review 3.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 4.  Glipizide: a review of its pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

5.  Binding study of the fluorescence probe 1-anilino-8-naphthalensulfonate to human plasma and human and bovine serum albumin using potentiometric titration.

Authors:  G N Valsami; P E Macheras; M A Koupparis
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

Review 6.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

7.  Binding of sulphonylureas to plasma proteins - A KATP channel perspective.

Authors:  Peter Proks; Holger Kramer; Elizabeth Haythorne; Frances M Ashcroft
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.